title: Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
authors.forename: Bob
authors.initials: B
authors.lastname: Roehr
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D002648:Child; D016265:Conflict of Interest / Q000191:economics / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D004363:Drug Utilization / Q000191:economics / Q000331:legislation & jurisprudence; D004992:Ethics, Medical; D004994:Ethics, Pharmacy; D006801:Humans; D040541:Marketing / Q000941:ethics* / Q000331:legislation & jurisprudence*; D008484:Medicaid / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D056687:Off-Label Use / Q000191:economics / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010819:Physician's Role; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D011570:Psychiatry / Q000191:economics / Q000941:ethics* / Q000331:legislation & jurisprudence*; D018570:Risk Assessment / Q000191:economics / Q000331:legislation & jurisprudence; D014481:United States
chemical_list: D014150:Antipsychotic Agents